Keywords
mystical experiences
psychedelics
psychedelic-assisted therapy
subjective well-being
How to Cite
Abstract
Respondents with experience in the use of psychedelics (psilocybin, LSD, ketamine, MDMA, etc.) participated in the study. Based on the subjective assessment of the level of awareness in the topic of psychedelics, it was found that 49% of respondents have a high level, 47% have an average level, and 4% have a low level of awareness in the topic. Most of the study participants were in Ukraine (84%); outside Ukraine, in particular in such countries as Germany, Israel, Bulgaria, the USA, England, Switzerland, Spain and the Czech Republic were 16% of participants. With the help of correlation analysis and the analysis of the significance of the differences between the average values of the studied indicators, the nature of the connection between the psychological well-being of the individual and the mystical experience produced by psychedelics was revealed. It has been established that the subjective awareness of the subject of psychedelics is not directly related to the actual mystical experience that arises as a result of the use of psychedelics, therefore the mystical experience is not a part of "self-suggestion", it is a real phenomenon. The mystical experience produced by psychedelics has been shown to be related to the subjective well-being of the individual, especially to happiness as its structural element, particularly in terms of a sense of unity, euphoria, and a sense of timelessness or boundary-breaking.
References
Donchev, F. A. (2020). Kohnityvno-povedinkovi ta farmakolohichni metody vdoskonalennya psykhichnoho komponentu osobystosti. OSOBYSTISNE ZROSTANNYA V UMOVAKH TRANSFORMATSIYI SUCHASNOHO SUSPILʹSTVA. [Cognitive-behavioral and pharmacological methods of improving the mental component of personality. PERSONAL GROWTH IN THE CONDITIONS OF TRANSFORMATION OF MODERN SOCIETY.]. Monohrafiya, Zhytomyr, O. O. Yevenok - Monograph, Zhytomyr, O. O. Evenok, 258-273 [in Ukrainian]
Dyumina, O. (2012). PSYKHOLOHICHNA KHARAKTERYSTYKA ZMINENYKH STANIV SVIDOMOSTI. [PSYCHOLOGICAL CHARACTERISTICS OF ALTERED STATES OF CONSCIOUSNESS]. Suchasni vymiry praktychnoyi psykholohiyi, zbirnyk naukovykh robit, Nizhynsʹkyy derzhavnyy universytet imeni Mykoly Hoholya - Modern dimensions of practical psychology, collection of scientific works, Mykola Gogol Nizhyn State University, 80. [in Ukrainian]
Hrof, S. (2015). Psykholohiya maybutnʹoho: uroky z suchasnykh doslidzhenʹ svidomosti. [Psychology of the future: lessons from modern research on consciousness.] Lʹviv, Afina. [in Ukrainian]
Matrenytsʹkyy, V. L. (2022). Renesans psykhodelichnoyi terapiyi ta yiyi znachennya dlya Ukrayiny. [Renaissance of psychedelic therapy and its significance for Ukraine]. Likarsʹka sprava - Medical case, (3-4), 37-59. [in Ukrainian]
Orlov, O. V. (2022). Obgruntuvannya mozhlyvosti vykorystannya psykhofarmakoterapevtychnykh metodiv dlya podolannya nehatyvnoho vplyvu rosiysʹkoyi viyny na psykhichne zdorovʺya naselennya. [Justification of the possibility of using psychopharmacotherapeutic methods to overcome the negative impact of the Russian war on the mental health of the population.] Insight: the psychological dimensions of society, (7), 103-117. [in Ukrainian]
Andersen, M., Schjoedt, U., Nielbo, K. L., & Sørensen, J. (2014). Mystical experience in the lab. Method & Theory in the Study of Religion, 26(3), 217-245.
Barrett, F. S., & Griffiths, R. R. (2018). Classic hallucinogens and mystical experiences: phenomenology and neural correlates. Behavioral neurobiology of psychedelic drugs, 393-430.
Beaussant, Y., Tulsky, J., Guérin, B., Schwarz-Plaschg, C., Sanders, J. J., & Radcliffe Institute for Advanced Study Working Group on Psychedelic Research in Serious Illness. (2021). Mapping an agenda for psychedelic-assisted therapy research in patients with serious illness. Journal of Palliative Medicine, 24(11), 1657-1666.
Bird, C. I., Modlin, N. L., & Rucker, J. J. (2021). Psilocy-bin and MDMA for the treatment of trauma-related psychopathology. International Review of Psychia-try, 33(3), 229-249.
Bornemann, J. (2020). The viability of microdosing psychedelics as a strategy to enhance cognition and well-being-an early review. Journal of Psychoactive Drugs, 52(4), 300-308.
Bright, S., Gringart, E., Blatchford, E., & Bettinson, S. (2021). A quantitative exploration of the relationships between regular yoga practice, microdosing psychedelics, wellbeing and personality variables. Australian Journal of Psychology, 73(2), 134-143.
Carlyle, M., Stevens, T., Fawaz, L., Marsh, B., Kosmider, S., & Morgan, C. J. (2019). Greater empathy in MDMA users. Journal of Psychopharmacology, 33(3), 295-304.
Chen, Z., Hood, Jr, R. W., Yang, L., & Watson, P. J. (2011). Mystical experience among Tibetan Buddhists: The common core thesis revisited. Journal for the Scientific Study of Religion, 50(2), 328-338.
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., ... & Emerson, A. (2018). Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology, 235(11), 3137-3148.
Davis, A. K., Barrett, F. S., & Griffiths, R. R. (2020). Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of contextual behavioral science, 15, 39-45.
Emerson, A., Ponté, L., Jerome, L., & Doblin, R. (2014). History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS). Journal of psychoactive drugs, 46(1), 27-36.
Friedman, H. S., & Kern, M. L. (2014). Personality, well-being, and health. Annual review of psychology, 65, 719-742.
Hawkswell, S. (2021). TheraPsil: Open Letter to Heatlh Canada. TheraPsil
Hood, R. W., Hill, P. C., & Spilka, B. (2009). The psychology of religion: An empirical approach. New York. NY: Guilford.
Hoskins, M., Pearce, J., Bethell, A., et al. (2018). Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis.)
Lidke, J. S. (2005). Interpreting across mystical boundaries: An analysis of Samādhi in the Trika-Kaula tradition. In Theory and practice of yoga (pp. 143-179). Brill.
MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011). Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of psychopharmacology, 25(11), 1453-1461.
MacLean, K. A., Leoutsakos, J. M. S., Johnson, M. W., & Griffiths, R. R. (2012). Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin. Journal for the scientific study of religion, 51(4), 721-737.
MAPS. (2020). Israel Embraces Research on MDMA-Assisted Therapy for PTSD;
Maslow, A. H. (1959). Cognition of being in the peak experiences. The Journal of Genetic Psychology, 94(1), 43-66.
Patra, S. (2016). Return of the psychedelics: Psilocybin for treatment resistant depression. Asian journal of psychiatry, 24, 51-52.
Qiu, T. T., & Minda, J. P. (2022). Psychedelic experiences and mindfulness are associated with improved wellbeing. Journal of psychoactive drugs, 1-11.
Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. (2018). Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology, 142, 263-269.
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019). Emotional breakthrough and psychedelics: validation of the emotional breakthrough inventory. Journal of psychopharmacology, 33(9), 1076-1087.
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018). Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in pharmacology, 8, 974.
Schmid, Y., & Liechti, M. E. (2018). Long-lasting subjective effects of LSD in normal subjects. Psychopharmacology, 235, 535-545.
Schmid, Y., Gasser, P., Oehen, P., & Liechti, M. E. (2021). Acute subjective effects in LSD- and MDMA-assisted psychotherapy. J. Psychopharmacol., 35, 362–374.;
Spriggs, M. J., Kettner, H., & Carhart-Harris, R. L. (2021). Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, 26, 1265-1270.
Stace, W. T. (1960). Mysticism and philosophy. Philosophy, 37(140).
Yaden, D. B., & Griffiths, R. R. (2020). The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacology & Translational Science, 4(2), 568-572.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Tetiana Kudrina, Anna Kozlovska